Search results
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks via Yahoo Finance· 3 hours agoApellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus...
$4 million bond issued for man accused of giving fatal dose of Benadryl to 3-year-old boy
WBNS-10TV Columbus· 4 days agoA Franklin County judge issued a $4 million bond for a man who allegedly gave a 3-year-old boy a...
Earnings call: Assertio Holdings reports growth and CEO search progress By Investing.com
Investing.com· 9 hours agoAssertio Holdings (ASRT) has provided a detailed overview of their first-quarter financial...
Enanta Pharmaceuticals Inc (ENTA) (Q2 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 12 hours agoQ: What doses of EDP-323 are you testing in the Phase IIa human challenge study? A: Jay Luly responded that they are testing two regimens: one with a consistent 600 mg dose
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302
Digital Journal· 6 hours ago...the " Company "), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces the submission to ethics of a trial entitled "A Phase 1, Randomized, Double-Blind, Placebo-Controlled,...
One Dose of LSD Med Yields Rapid, Durable Response for GAD
Medscape· 14 hours agoA single oral administration of an LSD-based medicine provided rapid and durable improvement in...
AP source: J&J doses to be released, but many will be tossed
AOL· 7 days agoU.S. regulators are allowing for the release of 10 million doses of Johnson & Johnson's COVID-19...
IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus.com via Yahoo Finance· 7 hours agoThe reported loss per share of $0.53 also slightly exceeded the anticipated $0.51. Company Overview...saw significant advancements in IDEAYAs clinical programs. Noteworthy developments include ...
FibroGen Inc (FGEN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 11 hours agoThe study is still in the dose escalation phase, and it's too early to set a benchmark for success. The focus is on radiographic progression-free survival as a potential registration ...
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
GuruFocus.com via Yahoo Finance· 12 hours agoNet Revenue: $45.3 million for the quarter. Total Net Revenue: Exceeded $95 million over the first three quarters since launch. Earnings Per Share (EPS) ...